Joshua Ruch
CIK: 0000943431
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GeneDx Holdings Corp.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 18, 2026WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
4.2K shares- - Jun 18, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct3.6K shares- - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect1.8K shares at avg. $160.45$290K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect2K shares at avg. $158.40$319K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect6.3K shares at avg. $159.28$1.0M - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect8.9K shares at avg. $160.45$1.4M - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect11.2K shares at avg. $161.16$1.8M - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect728 shares at avg. $162.04$118K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect201 shares at avg. $158.40$32K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect625 shares at avg. $159.28$100K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect889 shares at avg. $160.45$143K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect1.1K shares at avg. $161.16$180K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect72 shares at avg. $162.04$12K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect407 shares at avg. $158.40$64K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect1.3K shares at avg. $159.28$202K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect2.3K shares at avg. $161.16$366K - Nov 24, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect147 shares at avg. $162.04$24K - Jun 18, 2025WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
3.6K shares- - Jun 18, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct12.9K shares- - Feb 5, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct5.8K shares at avg. $7.89$46K - Jan 17, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct3K shares at avg. $7.89$24K - Oct 15, 2024WGS
GeneDx Holdings Corp.
Exercise(M)Direct130 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 4,248 | - | - | Direct |
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 3,576 | - | $0 | Direct |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 1,805 | $160.45 | $289,611 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 2,016 | $158.40 | $319,342 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 6,279 | $159.28 | $1,000,093 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 8,944 | $160.45 | $1,435,059 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 11,234 | $161.16 | $1,810,437 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 728 | $162.04 | $117,964 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 201 | $158.40 | $31,839 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 625 | $159.28 | $99,547 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 889 | $160.45 | $142,640 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 1,117 | $161.16 | $180,012 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 72 | $162.04 | $11,667 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 407 | $158.40 | $64,470 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 1,268 | $159.28 | $201,962 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 2,268 | $161.16 | $365,504 | Indirect |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 147 | $162.04 | $23,820 | Indirect |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 3,576 | - | - | Direct |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 12,924 | - | - | Direct |
| Feb 5, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 5,816 | $7.89 | $45,888 | Direct |
| Jan 17, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 3,000 | $7.89 | $23,670 | Direct |
| Oct 15, 2024 | WGS GeneDx Holdings Corp. | Exercise(M) | 130 | - | $0 | Direct |
1-22 of 22 transactions
About RUCH JOSHUA
RUCH JOSHUA (SEC CIK 0000943431) files insider reports with the SEC as Director of GeneDx Holdings Corp. (WGS).
Signal8 holds 7 ownership filings by RUCH JOSHUA, all Form 4s, filed between Oct 17, 2024 and Jun 23, 2026. Those filings report 22 transactions, from Oct 15, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RUCH JOSHUA's filings is in STAMFORD, CT.
Recent filings by RUCH JOSHUA
- Jun 18, 2026: Grant or award of WGS derivative securities (Form 4, code A).
- Jun 18, 2026: Option exercise of WGS shares (Form 4, code M).
- Nov 24, 2025: Open-market sales of WGS shares (15 lines, Form 4, code S).
- Jun 18, 2025: Grant or award of WGS derivative securities (Form 4, code A).
- Jun 18, 2025: Option exercise of WGS shares (Form 4, code M).
Other insiders filing for GeneDx Holdings Corp. (WGS)
- Stueland Katherine, CHIEF EXECUTIVE OFFICER
- Feeley Kevin, CHIEF FINANCIAL OFFICER
- Fuchs Thomas, Director
- GARDNER MARK A, President
- Ryan Jason, Director
- PFENNIGER RICHARD C JR, Director